FDA Eyes Manufacturing Innovation to Boost Drug Development

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-05-02-2004, Volume 28, Issue 5

New technologies, along with changes in FDA oversight, may provide a critical path to make more new drugs available more quickly to patients.

Related Content:

ManufacturingQuality SystemsRegulatory WatchPharmaceutical Technology-05-02-2004
Driving Dosage Form Developments
Control Strategy: A Feedback-Feedforward ‘Controls Hub’ for Risk, Knowledge, and Product Lifecycle Management
Considering Advances in Twin-Screw Extrusion for Solid-Dosage Drugs